Upper Airway and Otorhinolaryngologıc Complications In Renal Transplant Recipients

Yazarlar

İlda Tanrısever Pehlivan
https://orcid.org/0000-0002-9134-3070

Özet

Renal transplantation significantly improves survival and quality of life in patients with end-stage renal disease. However, lifelong immunosuppressive therapy predisposes transplant recipients to a broad spectrum of infectious, inflammatory, and neoplastic complications involving the upper airway and otorhinolaryngologic system. Impairment of cellular immunity, disruption of mucosal barriers, and alterations in the sinonasal microbiome contribute to increased susceptibility to opportunistic infections and chronic inflammatory disorders. Chronic rhinosinusitis represents the most frequently encountered sinonasal complication, whereas invasive fungal rhinosinusitis, although less common, remains a life-threatening condition requiring urgent diagnosis and management. Oropharyngeal complications such as chronic pharyngitis, oral candidiasis, aphthous ulcers, and herpes simplex infections are frequently observed and may significantly impair nutritional status and quality of life. Otologic manifestations, including otitis externa, otitis media, and drug-related ototoxicity, may also occur during the post-transplant period. In addition, prolonged immunosuppression increases the risk of head and neck malignancies and post-transplant lymphoproliferative disorders. Early recognition of symptoms, prompt endoscopic evaluation, radiologic imaging, and microbiological or histopathological confirmation are essential for accurate diagnosis. Management requires a multidisciplinary approach involving nephrologists, otorhinolaryngologists, infectious disease specialists, and transplant surgeons. This chapter reviews the epidemiology, pathophysiology, clinical presentation, diagnostic evaluation, and current management strategies for upper airway and otorhinolaryngologic complications in renal transplant recipients.

Referanslar

Valencia-Sanchez BA, Daniel H, Wilson P, et al. Incidence and Risk Factors for De Novo Chron- ic Rhinosinusitis in Kidney and Liver Transplant Recipients. OTO Open. 2026;10(1):e70200. doi:10.1002/oto2.70200.

Lee AY, Jeong J, Heo KN, et al. Complications Associated with Immunosuppressive Agents in Solid Organ Transplant Recipients: A Nationwide Analysis. J Clin Med. 2025;14(10):3602. doi:10.3390/jcm14103602.

Husain S, Singh N. The Impact of Novel Immunosuppressive Agents on Infections in Organ Transplant Recipients and the Interactions of These Agents with Antimicrobials. Clin Infect Dis. 2002;35(1):53-61. doi:10.1086/340867.

Chak E, Saab S. Risk Factors and Incidence of De Novo Malignancy in Liver Transplant Recipients: A Systematic Review. Liver Int. 2010;30(9):1247-1258. doi:10.1111/j.1478-3231.2010.02290.x.

Moroni G, et al. Kidney Transplantation: Shifting the Focus from Graft Survival to Patient Health. Front Immunol. 2026;17:1738675. doi:10.3389/fimmu.2026.1738675.

Hizal E, Ozcan M, Sennaroglu L, et al. Otorhinolaryngologic Problems in Liver and Kidney Transplant Recipients. Exp Clin Transplant. 2018;16(Suppl 1):706-710.

Romano FR, Voegels RL, Butugan O. Chronic Rhinosinusitis: Current Concepts in Pathophysiol- ogy and Management. Braz J Otorhinolaryngol. 2025;91(2):101-110.

Andrade-Bonilla CM, et al. Chronic Rhinosinusitis and Quality of Life in Immunocompromised Patients. Rev Fac Med Hum. 2024;24(2):20-28.

Costantini E, Natale F, Carbone A, et al. Pelvic Organ Prolapse. In: Heesakkers J, Chapple C, De Ridder D, Farag F, eds. Practical Functional Urology. Springer International Publishing Swit- zerland; 2016. p.153-238.

Aull MJ, Trofe-Clark J. Infections in Transplant Recipients. In: Organ Transplantation: New Per- spectives and Therapeutic Strategies. IntechOpen; 2013.

Yayınlanan

1 Temmuz 2026

Lisans

Lisans